These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1816 related articles for article (PubMed ID: 8365647)

  • 1. The ribosome-inactivating, antiproliferative and teratogenic activities and immunoreactivities of a protein from seeds of Luffa aegyptiaca (Cucurbitaceae).
    Ng TB; Chan WY; Yeung HW
    Gen Pharmacol; 1993 May; 24(3):655-8. PubMed ID: 8365647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of antisera to recombinant, soluble N-acetylglucosaminyltransferase V and its visualization in situ.
    Chen L; Zhang N; Adler B; Browne J; Freigen N; Pierce M
    Glycoconj J; 1995 Dec; 12(6):813-23. PubMed ID: 8748159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of melanoma concurrent with progressive systemic sclerosis.
    Videtic GM; Lopez PG; Jones JV
    Cancer Invest; 1997; 15(3):224-6. PubMed ID: 9171856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the retinal pigment epithelium: a diagnostic and therapeutic challenge.
    Finger PT; McCormick SA; Davidian M; Walsh JB
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S22-7. PubMed ID: 8871146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous patterns of constitutive and heat shock induced expression of HLA-linked HSP70-1 and HSP70-2 heat shock genes in human melanoma cell lines.
    Dressel R; Johnson JP; Günther E
    Melanoma Res; 1998 Dec; 8(6):482-92. PubMed ID: 9918409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of adhesion molecule CD44 in metastatic brain tumors.
    Harabin-Słowińska M; Słowiński J; Konecki J; Mrówka R
    Folia Neuropathol; 1998; 36(3):179-84. PubMed ID: 9833394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An in vitro study on radiation-induced TNF gene therapy of cancer].
    Cao X; Zhang W; Wang J
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):161-4. PubMed ID: 9387244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
    Gould SW; Banwell PE; Rosin RD
    Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A special surface coil for high-resolution ocular MRI.
    Hosten N; Lemke AJ
    Front Radiat Ther Oncol; 1997; 30():20-5. PubMed ID: 9205881
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and activity of partial retro-inverso analogs of the antimetastatic laminin-derived peptide, YIGSR-NH2.
    Zhao M; Kleinman HK; Mokotoff M
    J Pept Res; 1997 Mar; 49(3):240-53. PubMed ID: 9151257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diagnostic application of monoclonal antibody on survival in melanoma patients.
    Bender H; Grapow M; Schomburg A; Reinhold U; Biersack HJ
    Hybridoma; 1997 Feb; 16(1):65-8. PubMed ID: 9085131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 expression in melanocytic lesions: a marker of malignant progression?
    Harwood CA; Green MA; Cook MG
    Br J Dermatol; 1996 Dec; 135(6):876-82. PubMed ID: 8977706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot study.
    Bernengo MG; Doveil GC; Bertero M; Quaglino P; Fierro MT; Savoia P; Appino A; Colonna S
    Melanoma Res; 1996 Jun; 6(3):257-65. PubMed ID: 8819129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.
    Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Rosenkaimer F; Gérain J; Klaase J; Kroon B; Vanderveken J; Schmitz P
    J Infus Chemother; 1995; 5(2):73-81. PubMed ID: 8521239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration.
    Kohn EC; Hollister GH; DiPersio JD; Wahl S; Liotta LA; Schiffmann E
    Int J Cancer; 1993 Apr; 53(6):968-72. PubMed ID: 8473054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion.
    Stern JB; Peck GL; Haupt HM; Hollingsworth HC; Beckerman T
    J Am Acad Dermatol; 1993 Apr; 28(4):591-4. PubMed ID: 8463460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of cutaneous nevocarcinomas].
    Banzet P; Belaich S; Civatte J; Puissant A; Jacquillat C; Israel L
    J Chir (Paris); 1976 Mar; 111(3):347-54. PubMed ID: 956292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure.
    Rosso S; Zanetti R; Pippione M; Sancho-Garnier H
    Melanoma Res; 1998 Dec; 8(6):573-83. PubMed ID: 9918420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor.
    Montero-Julian FA; Dauny I; Flavetta S; Ronsin C; André F; Xerri L; Wang MH; Marvaldi J; Breathnach R; Brailly H
    Hybridoma; 1998 Dec; 17(6):541-51. PubMed ID: 9890710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.